Jenn Buechel

Jenn brings over 20 years of experience in launching products in a wide variety of industries, with a particular focus on bringing novel healthcare technologies from R&D to market. Jenn is currently the Chief Operating Officer of Delfi Diagnostics, and has held product and operations leadership roles with GRAIL and Guardant Health. Prior to her work in diagnostics, she held roles of increasing responsibility at Genentech, Amyris Biotechnology, and McKinsey. Jenn earned an MSc Eng in Systems Engineering and an MBA from Stanford University, as well as a BSc Eng in Chemical Engineering and a BA in English from Queen’s University in Canada. Active in global nonprofit and policy work, Jenn is passionate about improving the accessibility of high-quality healthcare to the most underserved populations. She is a Fellow of the Aspen Institute's Health Innovators Fellowship and a member of the Aspen Global Leadership Network, in addition to being a frequent contributor to the World Economic Forum's Lung Cancer Collaboration and Global Biotech Council.